Ani Pharmaceuticals Inc (ANIP)

May 10, 2025

ANI Pharmaceuticals raises 2025 revenue guidance to $768M-$793M with 25%-29% growth - MSN

May 10, 2025

May 10, 2025

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 10, 2025

Earnings call transcript: ANI Pharmaceuticals beats Q1 2025 forecasts, stock surges - Investing.com India

May 10, 2025

May 10, 2025

ANI Pharmaceuticals Inc (ANIP) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada

May 10, 2025

May 10, 2025

Decoding ANI Pharmaceuticals Inc (ANIP): A Strategic SWOT Insigh - GuruFocus

May 10, 2025

May 10, 2025

ANI Pharmaceuticals Reports Record Q1 2025 Results - TipRanks

May 10, 2025

May 09, 2025

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact - AOL.com

May 09, 2025

May 09, 2025

ANI: Q1 Earnings Snapshot - The Washington Post

May 09, 2025

May 09, 2025

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 09, 2025

May 09, 2025

Transcript : ANI Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 09, 2025 - marketscreener.com

May 09, 2025

May 09, 2025

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

May 09, 2025

May 09, 2025

ANI Pharmaceuticals, Inc. Q1 Profit Decreases, But Beats Estimates - Nasdaq

May 09, 2025

May 09, 2025

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance - The Manila Times

May 09, 2025

May 09, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations - FinancialContent

May 09, 2025

May 09, 2025

(ANIP) ANI Pharmaceuticals Expects Fiscal Year 2025 Revenue Range $768M$793M - marketscreener.com

May 09, 2025

May 09, 2025

ANI Pharmaceuticals, Inc. Raises Earnings Guidance for the Year 2025 - marketscreener.com

May 09, 2025

May 08, 2025

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards? - MSN

May 08, 2025

May 08, 2025

ANI Pharmaceuticals Files Proxy for 2025 Meeting - TipRanks

May 08, 2025

May 08, 2025

ANI Pharmaceuticals Set to Announce Earnings Results: Key ExpectationsNews and Statistics - IndexBox

May 08, 2025

May 08, 2025

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow - FinancialContent

May 08, 2025

May 06, 2025

ANI Pharmaceuticals: A Short-Term Buying Opportunity (NASDAQ:ANIP) - Seeking Alpha

May 06, 2025

May 05, 2025

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance - ADVFN

May 05, 2025

May 05, 2025

ANI Pharmaceuticals (ANIP) Highlights Promising Cortrophin Gel P - GuruFocus

May 05, 2025

May 05, 2025

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

May 05, 2025

May 05, 2025

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model - GlobeNewswire

May 05, 2025

May 05, 2025

Breakthrough: ANI's Cortrophin Gel Achieves Dose-Dependent Success in Autoimmune Eye Disease Trial - Stock Titan

May 05, 2025

May 02, 2025

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 01, 2025

Scotiabank Announces Redemption of US $1,250 million 4.900% Fixed Rate Resetting Perpetual Subordinated Additional Tier 1 Capital Notes - The Globe and Mail

May 01, 2025

Apr 29, 2025

The 4.0% return this week takes ANI Pharmaceuticals' (NASDAQ:ANIP) shareholders three-year gains to 135% - simplywall.st

Apr 29, 2025

Apr 24, 2025

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI - Yahoo Finance

Apr 24, 2025

Apr 23, 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - TradingView

Apr 23, 2025

Apr 21, 2025

Truist raises ANI Pharmaceuticals target to $65, maintains hold By Investing.com - Investing.com India

Apr 21, 2025

Apr 21, 2025

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating - marketscreener.com

Apr 21, 2025

Apr 17, 2025

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Apr 17, 2025

Apr 15, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Apr 15, 2025

Apr 14, 2025

Ani Pharmaceuticals Sr. VP sells $27,583 in stock By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 13, 2025

StockNews.com Downgrades ANI Pharmaceuticals (NASDAQ:ANIP) to Sell - MarketBeat

Apr 13, 2025

Apr 11, 2025

Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings) - Benzinga

Apr 11, 2025

Apr 11, 2025

ANI Pharmaceuticals (ANIP) Set for Potential Earnings Beat - GuruFocus

Apr 11, 2025

Apr 09, 2025

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET - GlobeNewswire

Apr 09, 2025

Apr 09, 2025

ANI Pharmaceuticals Reveals Q1 2025 Earnings Date: Key Executive Insights Coming May 9 - Stock Titan

Apr 09, 2025

Apr 08, 2025

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE - Yahoo Finance

Apr 08, 2025

Apr 07, 2025

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 07, 2025